Toshiaki Iba Selected Research

Toshiaki Iba Research Topics

Disease

97	Sepsis (Septicemia) 05/2024 - 11/2002
71	Disseminated Intravascular Coagulation 05/2024 - 06/2003
35	Thrombosis (Thrombus) 05/2024 - 01/2005
22	Hemorrhage 05/2024 - 06/2003
18	COVID-19 03/2024 - 01/2020
17	Infections 02/2024 - 01/2005
17	Septic Shock (Toxic Shock Syndrome) 01/2022 - 12/2011
16	Inflammation (Inflammations) 01/2024 - 11/2007
10	Thrombocytopenia (Thrombopenia) 03/2024 - 10/2007
9	Neoplasms (Cancer) 01/2022 - 06/2003
8	Critical Illness (Critically Ill) 05/2024 - 01/2005
7	Shock 03/2023 - 12/2011
5	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2024 - 11/2007
4	Thromboembolism 05/2024 - 01/2020
4	Communicable Diseases (Infectious Diseases) 02/2024 - 01/2019
4	Pneumonia (Pneumonitis) 12/2023 - 07/2006
4	Multiple Organ Failure (MODS) 11/2023 - 03/2009
4	Wounds and Injuries (Trauma) 11/2022 - 12/2008
4	Venous Thromboembolism 01/2020 - 07/2016
4	Endotoxemia 01/2017 - 09/2003
3	Thromboinflammation 02/2024 - 05/2023
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 11/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2003
3	Body Weight (Weight, Body) 05/2015 - 12/2003
2	Soft Tissue Infections 12/2023 - 11/2023
2	Heat Stroke (Heatstroke) 03/2023 - 02/2022
2	Disease Progression 01/2023 - 11/2022
2	Pain (Aches) 01/2022 - 05/2012
2	Dyspnea (Shortness of Breath) 01/2022 - 09/2013
2	Vasculitis (Vasculitides) 12/2020 - 01/2020
2	Thrombotic Microangiopathies 02/2020 - 01/2018
2	Hemophilia A (Haemophilia) 01/2020 - 01/2019
2	Thrombotic Thrombocytopenic Purpura 01/2019 - 01/2018
2	Hemolytic-Uremic Syndrome 01/2019 - 01/2018
1	Hyperglycemia 04/2024
1	Bacterial Infections (Bacterial Infection) 04/2023
1	Vasoplegia 02/2023
1	Hypersensitivity (Allergy) 01/2023
1	Confusion (Bewilderment) 11/2022

Drug/Important Bio-Agent (IBA)

69	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 06/2003
39	AntithrombinsIBA 01/2024 - 11/2002
35	AnticoagulantsIBA 05/2024 - 12/2004
24	ThrombomodulinIBA 01/2024 - 01/2009
14	Heparin (Liquaemin)FDA LinkGeneric 05/2024 - 08/2005
9	Fibrinogen (Factor I)FDA Link 02/2023 - 01/2008
8	CytokinesIBA 01/2024 - 01/2014
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 11/2007
8	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022 - 12/2011
8	LipopolysaccharidesIBA 06/2017 - 02/2005
7	fibrin fragment D (D-dimer)IBA 04/2023 - 01/2020
7	Protein CIBA 01/2017 - 12/2004
6	VaccinesIBA 03/2024 - 07/2021
5	Hemostatics (Antihemorrhagics)IBA 02/2024 - 01/2005
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 10/2017
5	Histones (Histone)IBA 02/2022 - 01/2013
4	ChemokinesIBA 01/2024 - 06/2017
4	C-Type Lectins (C-Type Lectin)IBA 07/2023 - 06/2021
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2024 - 01/2010
3	FibrinIBA 04/2023 - 06/2003
3	Platelet Factor 4IBA 02/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 02/2022 - 01/2015
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2019 - 11/2009
3	Fondaparinux (Arixtra)FDA Link 07/2016 - 01/2012
3	Factor Xa InhibitorsIBA 07/2016 - 10/2013
3	danaparoid (Orgaran)FDA Link 01/2008 - 06/2003
2	CatecholaminesIBA 04/2024 - 11/2012
2	EnzymesIBA 03/2024 - 01/2022
2	Tranexamic Acid (AMCA)FDA Link 12/2023 - 12/2021
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2023 - 03/2023
2	RNA (Ribonucleic Acid)IBA 09/2023 - 12/2003
2	Thrombin FDA Link 08/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	RivaroxabanIBA 10/2022 - 02/2014
2	EndotoxinsIBA 12/2020 - 11/2018
2	CathelicidinsIBA 10/2020 - 02/2016
2	Complement System Proteins (Complement)IBA 01/2019 - 01/2018
2	Fibrin Fibrinogen Degradation ProductsIBA 09/2017 - 01/2008
2	HMGB1 Protein (HMG1)IBA 06/2017 - 01/2013
2	Antithrombin IIIIBA 07/2016 - 06/2003
2	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 01/2013
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2014 - 01/2014
2	SteroidsIBA 11/2012 - 05/2012
2	Cilostazol (Pletal)FDA LinkGeneric 02/2008 - 11/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024
1	Phenobarbital (Luminal)FDA Link 04/2024
1	Oxygen (Dioxygen)IBA 02/2024
1	Thromboplastin (Tissue Factor)IBA 02/2023
1	von Willebrand FactorIBA 02/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Protamines (Protamine Sulfate)FDA Link 01/2023

Therapy/Procedure

39	Therapeutics 05/2024 - 11/2002
10	Critical Care (Surgical Intensive Care) 12/2023 - 01/2008
7	Hemoperfusion 01/2022 - 12/2011
5	Punctures 10/2020 - 11/2009
3	Ligation 10/2020 - 01/2016
3	Intravenous Infusions 07/2014 - 12/2011
2	Resuscitation 04/2024 - 12/2023
2	Drug Therapy (Chemotherapy) 10/2004 - 12/2003
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2024